Q-omics provides the consensus-scored MIR6765 profile across patient tissues and cancer cell-line models. MIR6765 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in ACC. Additionally, MIR6765 RNA expression shows 6,976 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight ACC, and THYM as cancer lineages where MIR6765 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.